Stockreport

LENZ Therapeutics to Participate in Upcoming Investor Conferences

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused [Read more]